Speakers

Meet Our Esteemed Speakers

Explore the key opinion leaders and renowned academic experts who bring unparalleled knowledge and thought leadership to our annual events.

Biomarkers Speakers

30 September - 01 October 2024 | Basel, Switzerland

Biomarkers Europe 2024

Benjamin Weber
Vice President Translational Research,
Novo Nordisk
Brian Lockhart
Global Heaf of Companion Diagnostics,
Servier
Ed Schuuring
Clinical Scientist in Molecular Pathology,
University Medical Center Groningen
Gunther Jansen
Head of Multimodal Data & Analytics,
Novartis
Joanna Janus
Research Programme Manager (Early Detection and Prevention),
Cancer Research UK
Olga Nissan
CEO,
Protica Bio

All Speakers

Amanda Heslegrave
Senior Research Fellow,
University College London
Axel Ducret
expert scientist,
F. Hoffmann-La Roche Ltd
Bernhard Reis
Biomarker Lead,
F. Hoffmann-La Roche Ltd.
Bernhard Reis
Expert Biomarker & Translational Medicine Leader; Group Head Biomarker Strategy,
F. Hoffman-La Roche Ltd.
Christian Ruiz
Senior Lecturer; Chief Scientific Officer,
University of Basel; Moonlight AI
Christophe Le Tourneau
Medical Oncologist,
Institut Curie
Cornelia Wilson
Reader and Academic Laboratory Director,
Canterbury Christ Church University
Dirk Kemming
Regional Medical Director Diagnostics,
Daiichi Sankyo
Dylan Powell
Lecturer Public Health and Innovation,
Stirling University
Fatima Sanfourche
Senior Director of QA & RA Compliance for Medical Devices and eHealth,
Bayer
Gro Live Fagereng
Project Manager of the EU-project PRIME-ROSE and Coordinator Precision Cancer Medicine at OUH Centre for Precision Cancer Medicine,
Oslo Universitetssykehus
Guillaume Desachy
Head Of Biometrics,
Pierre Fabre
Jacques Colinge
Professor,
University of Montpellier, France
Jehad Charo
Principal scientist - Biomarker Experimental Medicine Leader,
Hoffmann La Roche Ltd
Jon Krell
Senior Clinical Lecturer and Honorary Consultant in Medical Oncology,
Imperial College London
Jose MG Izarzugaza
Head of Department,
Novo Nordisk
Maximilian Breitner
Laboratory Head Bioanalytics,
Sandoz
Michael Cannarile
Expert Biomarker & Translational Medicine Leader; Group Head Biomarker Strategy,
China Innovation Center of Roche
Michael Zaiac
Head of Medical Affairs Oncology Region Europe,
Daiichi Sankyo
Nolwen Guigal-Stephan
Head of Clinical Biomaker Development,
Servier Monde
Pekka Ruusuvuori
Assistant Professor, PI in Bioimage informatics Institute of Biomedicine,,
Turku University
Philip Beer
Chief Scientific Officer,
Step Pharma
Rodrigo Toledo
Group Leader,
Vall d'Hebron Institute of Oncology
Shashank Saran
Associate Director,
AstraZeneca
Thomas Jensen
Chief Executive Officer,
Allarity

28 - 29 October 2024 | San Diego, CA, USA

Biomarkers US 2024

Anmarie Boutrin
Global Regulatory Affairs Scientist,
UCB
Heather Cohen
Senior Director,
Bicycle Therapeutics
Minghao Song
Director, Precision Medicine Lead,
AstraZeneca
Robert Getzenberg
Medical Director Diagnostics, Oncology,
OSI Pharmaceuticals
William Weber
Associate Scientific Director,
Takeda
Yang Li
Principal Scientist,
Ionis Pharmaceuticals

12 - 14 February 2025 | London, UK

Biomarkers 2025

Belinda Nedjai
Associate Professor,
Queen Mary University of London
Debayan Mukherjee
Principal Scientist,
GSK
Dmitri Mikhailov
Director,
Novartis
Julie Lin
Global Project Head, Rare Disease,
Sanofi